Cargando…
Association between Genetic Polymorphisms and Bleeding in Patients on Direct Oral Anticoagulants
Objectives: The purpose of our study is to investigate the effects of apolipoprotein B (APOB) and APOE gene polymorphisms on bleeding complications in patients receiving direct oral anticoagulants (DOACs). Methods: A total of 16 single nucleotide polymorphisms (SNPs) in 468 patients were genotyped....
Autores principales: | Yoon, Ha-Young, Song, Tae-Jin, Yee, Jeong, Park, Junbeom, Gwak, Hye-Sun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9501033/ https://www.ncbi.nlm.nih.gov/pubmed/36145636 http://dx.doi.org/10.3390/pharmaceutics14091889 |
Ejemplares similares
-
Genetic Factors of Renin–Angiotensin System Associated with Major Bleeding for Patients Treated with Direct Oral Anticoagulants
por: Yee, Jeong, et al.
Publicado: (2022) -
Construction of a risk scoring system using clinical factors and RYR2 polymorphisms for bleeding complications in patients on direct oral anticoagulants
por: Jang, Eun Jeong, et al.
Publicado: (2023) -
Association between SLCO1B1 genetic polymorphisms and bleeding risk in patients treated with edoxaban
por: Han, Ji Min, et al.
Publicado: (2023) -
ABCG2 Gene Polymorphisms May Affect the Bleeding Risk in Patients on Apixaban and Rivaroxaban
por: Kim, Hamin, et al.
Publicado: (2023) -
Influence of CYP2C9 Genetic Polymorphisms on the Pharmacokinetics of Losartan and Its Active Metabolite E-3174: A Systematic Review and Meta-Analysis
por: Park, Yoon-A, et al.
Publicado: (2021)